BTAI Chart
See on advanced chart >
About
BioXcel Therapeutics, Inc. was incorporated as a Delaware corporation on March 29, 2017 as a wholly-owned subsidiary of BioXcel. BioXcel Therapeutics, Inc., or BTI, is a clinical stage biopharmaceutical company focused on drug development that utilizes novel...
Read More
- HighlightA biopharmaceutical company developing novel therapeutics for neuroscience and immuno-oncology disorders
- ExchangeNASDAQ
- Listing Date03/08/2018
- Established Date03/29/2017
- Full-time Employees74
- Address555 Long Wharf Drive New Haven CT 06511
- Tel1-475-2386837
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Pharmaceuticals